Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$3.89
-5.80%
Mkt Cap $367.40M
Analyst Ratings
Buy
0
Hold
6
Sell
1
Price Target (17 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+54.2%
Consensus $6.00 vs current $3.89